Nurix Therapeutics Inc.
World Rank (Jan-05-2024)
12,883
Market Cap (Jan-05-2024)
0.478 Billion USD
World Rank (Jul-30-2023)
13,148
Market Cap (Jul-30-2023)
0.469 Billion USD
World Rank (Dec-25-2022)
12,559
Market Cap (Dec-25-2022)
0.489 Billion USD
World Rank (Jan-07-2022)
8,355
Market Cap (Jan-07-2022)
1.23 Billion USD
Annual Revenue in USD
29 Million USD
Annual Net Income in USD
-117 Million USD
Annual Results for Period Ending
Nov-2021 ending year
Company Profile
Nurix Therapeutics is a Biopharmaceutical company discovers drugs that harness the bodies natural process to control protein levels and drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells as a unique therapeutic approach to treat a broad range of diseases. The company annual revenue is 17.8 million USD and 103 employees as on 2019. The headquarters is in USA.
Company Website